IL161319A0 - Use of thymulin-like peptides for making pain-relieving medicines - Google Patents

Use of thymulin-like peptides for making pain-relieving medicines

Info

Publication number
IL161319A0
IL161319A0 IL16131902A IL16131902A IL161319A0 IL 161319 A0 IL161319 A0 IL 161319A0 IL 16131902 A IL16131902 A IL 16131902A IL 16131902 A IL16131902 A IL 16131902A IL 161319 A0 IL161319 A0 IL 161319A0
Authority
IL
Israel
Prior art keywords
thymulin
peptides
pain
relieving medicines
making pain
Prior art date
Application number
IL16131902A
Other languages
English (en)
Inventor
Nayef Saade
Bared Safieh-Garabedian
Original Assignee
Centre Nat Rech Scient
Inst Nat Sante Et Dela Rech Me
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Inst Nat Sante Et Dela Rech Me filed Critical Centre Nat Rech Scient
Publication of IL161319A0 publication Critical patent/IL161319A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL16131902A 2001-10-09 2002-10-08 Use of thymulin-like peptides for making pain-relieving medicines IL161319A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0112984A FR2830451B1 (fr) 2001-10-09 2001-10-09 Utilisation de peptides analogues de la thymuline(pat)pour la fabrication de medicaments contre la douleur
PCT/FR2002/003428 WO2003030927A2 (fr) 2001-10-09 2002-10-08 Utilisation de peptides analogues de la thymuline (pat) pour la fabrication de medicaments contre la douleur

Publications (1)

Publication Number Publication Date
IL161319A0 true IL161319A0 (en) 2004-09-27

Family

ID=8868083

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16131902A IL161319A0 (en) 2001-10-09 2002-10-08 Use of thymulin-like peptides for making pain-relieving medicines
IL161319A IL161319A (en) 2001-10-09 2004-04-07 Use of thymoline-like peptides for the preparation of analgesics

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL161319A IL161319A (en) 2001-10-09 2004-04-07 Use of thymoline-like peptides for the preparation of analgesics

Country Status (11)

Country Link
US (1) US7309690B2 (de)
EP (1) EP1450843B1 (de)
JP (1) JP4277684B2 (de)
AT (1) ATE334694T1 (de)
AU (1) AU2002362710B2 (de)
CA (1) CA2463549C (de)
DE (1) DE60213648T2 (de)
ES (1) ES2272811T3 (de)
FR (1) FR2830451B1 (de)
IL (2) IL161319A0 (de)
WO (1) WO2003030927A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG192300A1 (en) 2003-01-28 2013-08-30 Ironwood Pharmaceuticals Inc Methods and compositions for the treatment of gastrointestinal disorders
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
CN102772783A (zh) * 2007-01-25 2012-11-14 中国生化制药工业协会 血清胸腺因子在制备抗肿瘤药物、肿瘤物理及化学治疗药物的保护药物方面的用途
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
FR2930156B1 (fr) * 2008-04-21 2011-10-28 Cll Pharma Utilisation du nonapeptide pat dans le traitement des maladies autoimmunes.
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
WO2010065751A2 (en) 2008-12-03 2010-06-10 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase c agonists and methods of use
WO2010078449A2 (en) 2008-12-31 2010-07-08 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US9468662B2 (en) 2010-07-12 2016-10-18 Orphit Use of the PAT nonapeptide in the treatment and prevention of neurodegenerative diseases
FR2962335B1 (fr) 2010-07-12 2013-01-18 Cll Pharma Utilisation du nonapeptide pat dans le traitement et la prevention des maladies neurodegeneratives
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9580471B2 (en) 2011-03-01 2017-02-28 Synergy Pharmaceuticals, Inc. Process of preparing guanylate cyclase C agonists
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
CN104902930A (zh) 2012-08-21 2015-09-09 阿德利克斯公司 在治疗与液体潴留或盐分过载相关的疾病和胃肠道疾病中用于抑制nhe-介导的反向转运的化合物和方法
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
EP2970384A1 (de) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonisten der guanylatcyclase und deren verwendungen
HUE044550T2 (hu) 2013-04-12 2019-11-28 Ardelyx Inc NHE-3 megkötõ vegyületek és foszfát transzport gátlási módszerek
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
CN109219444A (zh) * 2016-06-06 2019-01-15 临床干细胞有限公司 用于毛发生长的肽
CN110267944B (zh) 2017-01-09 2024-03-08 阿德利克斯股份有限公司 可用于治疗胃肠道病症的化合物
JP2020505333A (ja) 2017-01-09 2020-02-20 アルデリックス， インコーポレイテッド Ｎｈｅ媒介性アンチポートの阻害薬

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1156766B (it) * 1977-05-25 1987-02-04 Anvar Polipeptidi dotati di attivita' timica o antagonista e procedimento per la loro sintesi
GR75636B (de) 1980-05-22 1984-08-02 Inst Nat Sante Rech Med
JPS5852225A (ja) * 1981-09-22 1983-03-28 Mitsui Pharmaceut Inc 脱髄疾患治療剤
US5288706A (en) * 1987-12-25 1994-02-22 Mitsui Toatsu Chemicals, Incorporated Medicament for prevention and remedy of diseases of the pancreas and others
JPH06192120A (ja) * 1992-12-24 1994-07-12 Mitsui Toatsu Chem Inc 腎臓の組織・細胞の損傷・破壊の予防・治療剤
JP3751986B2 (ja) * 1994-06-21 2006-03-08 英良 横沢 医薬組成物
US5639726A (en) * 1994-09-30 1997-06-17 The Regents Of The University Of Michigan Peptide mediated enhancement of thrombolysis methods and compositions
US5808009A (en) * 1996-09-23 1998-09-15 North Dakota State University Research Foundation Method of affinity purifying antibodies

Also Published As

Publication number Publication date
US7309690B2 (en) 2007-12-18
ES2272811T3 (es) 2007-05-01
CA2463549A1 (fr) 2003-04-17
EP1450843A2 (de) 2004-09-01
AU2002362710B8 (en) 2003-04-22
AU2002362710B2 (en) 2007-06-28
FR2830451B1 (fr) 2004-04-30
ATE334694T1 (de) 2006-08-15
DE60213648D1 (de) 2006-09-14
JP4277684B2 (ja) 2009-06-10
WO2003030927A3 (fr) 2003-10-09
FR2830451A1 (fr) 2003-04-11
CA2463549C (fr) 2011-12-20
WO2003030927A2 (fr) 2003-04-17
EP1450843B1 (de) 2006-08-02
JP2005515972A (ja) 2005-06-02
IL161319A (en) 2008-11-26
US20050261194A1 (en) 2005-11-24
DE60213648T2 (de) 2007-08-02

Similar Documents

Publication Publication Date Title
IL161319A0 (en) Use of thymulin-like peptides for making pain-relieving medicines
YU37304A (sh) Specifični agensi koji vezuju humani angiopoetin-2
PT910647E (pt) Variantes hiperactivas da dnase i humana
DE60034865D1 (de) Alloferone - immunomodulierende Peptide
PT1019040E (pt) Inibicao da actividade de p38-quinase por meio de arilureias
IL161591A0 (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
ATE429922T1 (de) Topische gel-abgabesysteme zur behandlung von hauterkrankungen
NL300830I1 (nl) Protein Q, een recombinant chimeer eiwit, bestaande uit vijf antigenefragmenten van vier verschillende Leishmania infantum (zymodeme Mon-1) eiwitten
DE69928093D1 (de) Kombinationspräparat enthaltend monozyten-abgeleitete zellen zur behandlung von neoplastischen oder infektiösen erkrankungen
WO2003100574A3 (en) Dental appliances and systems and methods for distributing dental appliances
YU68702A (sh) Novi lhrh-antagonisti, njihova proizvodnja i upotreba kao leka
MXPA04004306A (es) Uso de antagonistas del receptor de endotelina para el tratamiento de enfermedades tumorales.
NZ512659A (en) Use of growth hormone secretagogues for treatment of physical performance decline
EP1401474A4 (de) Verfahren zum auslösen einer anhaltenden immunreaktion
DE69831257D1 (de) Histogranin peptide und deren analgetische verwendung
IL149416A0 (en) Human enzymes of the metalloprotease family
PT1056458E (pt) Tratamento de dor cronica
UA83989C2 (ru) Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение
MXPA04001986A (es) Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
AU2001278884A1 (en) Anti-hiv and anti-tumor peptides and fragments of lysozyme
IL174134A0 (en) Use of a protein in the preparation of a medicament for treatment of fibrotic diseases
WO2001014415A3 (en) Egfh2 genes and gene products
WO2003022883A3 (de) Verwendung eines proteins zur herstellung eines medikaments zur stimulierung des angeborenen unspezifischen immunsystems
MXPA01006319A (es) Uso de los antagonistas del receptor para 5ht, para el tratamiento de sindrome de fatiga cronica.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed